INTERNATIONAL PATENT: REVISAN HEALTHCARE GMBH FILES APPLICATION FOR "A COMBINATION OF VASOACTIVE INTESTINAL PEPTIDE (VIP) RECEPTOR AGONIST AND A MUCOLYTIC AGENT AGAINST INFLAMMATORY DISEASES OF THE RESPIRATORY TRACT"

GENEVA, Oct. 13 -- REVISAN HEALTHCARE GMBH (Alte BundesstraBe 2079194 Gundelfingen) filed a patent application (PCT/EP2025/058999) for "A COMBINATION OF VASOACTIVE INTESTINAL PEPTIDE (VIP) RECEPTOR AGONIST AND A MUCOLYTIC AGENT AGAINST INFLAMMATORY DISEASES OF THE RESPIRATORY TRACT" on Apr 02, 2025. With publication no. WO/2025/210089, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KLAPPROTH, Holger (Kehler StraBe 1279108 Freiburg), BIRSNER, Ulrich (VorlingsbachstraBe 3179254 Oberried), HOPPE, Wolfgang Peter (Zum Roten S...